banner
PLGA-PEG-PLGA hydrogel-encapsulated doxorubicin liposomes (DOX-Lip-Gel)
Inquiry

Cat. No.: X26-05-ZQ1570

PLGA-PEG-PLGA hydrogel-encapsulated doxorubicin liposomes (DOX-Lip-Gel)

Synonym: PLGA-PEG-PLGA hydrogel doxorubicin liposomes; DOX liposome-loaded PLGA-PEG-PLGA hydrogels; DOX-Lip-Gel

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
This advanced composite formulation features poly(lactic-co-glycolic acid)-polyethylene glycol-poly(lactic-co-glycolic acid) hydrogel-encapsulated doxorubicin liposomes (DOX-Lip-Gel) designed with a matrix-reinforced architecture. The structural framework consists of high-purity phospholipid vesicles encapsulating hydrophilic doxorubicin hydrochloride (DOX), which are thoroughly embedded within a thermosensitive biodegradable poly(lactic-co-glycolic acid)-polyethylene glycol-poly(lactic-co-glycolic acid) (PLGA-PEG-PLGA) copolymer hydrogel network. This multi-layered composite matrix restricts the passive diffusion of the anthracycline drug and enhances mechanical resistance against osmotic stress, providing a sustained dual-barrier release profile.
Source
Custom synthesis
Functional Group
PLGA-PEG-PLGA; Doxorubicin
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.